| Sherry E Coffield, APN | |
|
1940 Alcoa Hwy, Suite E260, Knoxville, TN 37920-2244 | |
| (865) 305-6810 | |
| (865) 305-6803 |
| Full Name | Sherry E Coffield |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 39 Years |
| Location | 1940 Alcoa Hwy, Knoxville, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750552014 | NPI | - | NPPES |
| APN0000013069 | Other | TN | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | APN0000013069 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Health System, Inc. | 5294646378 | 526 |
News Archive
The health care reform law passed last year requires insurers to offer, at a minimum, a set of "essential" benefits to individuals and small groups. ... On Friday, however, the Department of Health and Human Services put out a bulletin proposing to let each state come up with its own definition.
Aethlon Medical, Inc., the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that the European Patent Office (EPO) has provided the Company a notice of intent to issue European Patent Application No. 04 703 672.8 entitled "Method For Removal of Viruses From Blood By Lectin Affinity Hemodialysis."
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
Low levels of a naturally occurring steroid are associated with an increased risk of heart and blood-vessel disease in elderly men, a new study finds. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
› Verified 4 days ago
| Entity Name | University Health System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790738763 PECOS PAC ID: 5294646378 Enrollment ID: O20031111000809 |
News Archive
The health care reform law passed last year requires insurers to offer, at a minimum, a set of "essential" benefits to individuals and small groups. ... On Friday, however, the Department of Health and Human Services put out a bulletin proposing to let each state come up with its own definition.
Aethlon Medical, Inc., the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that the European Patent Office (EPO) has provided the Company a notice of intent to issue European Patent Application No. 04 703 672.8 entitled "Method For Removal of Viruses From Blood By Lectin Affinity Hemodialysis."
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
Low levels of a naturally occurring steroid are associated with an increased risk of heart and blood-vessel disease in elderly men, a new study finds. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sherry E Coffield, APN 1940 Alcoa Hwy, Suite E260, Knoxville, TN 37920-2244 Ph: (865) 305-6810 | Sherry E Coffield, APN 1940 Alcoa Hwy, Suite E260, Knoxville, TN 37920-2244 Ph: (865) 305-6810 |
News Archive
The health care reform law passed last year requires insurers to offer, at a minimum, a set of "essential" benefits to individuals and small groups. ... On Friday, however, the Department of Health and Human Services put out a bulletin proposing to let each state come up with its own definition.
Aethlon Medical, Inc., the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, announced today that the European Patent Office (EPO) has provided the Company a notice of intent to issue European Patent Application No. 04 703 672.8 entitled "Method For Removal of Viruses From Blood By Lectin Affinity Hemodialysis."
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
Low levels of a naturally occurring steroid are associated with an increased risk of heart and blood-vessel disease in elderly men, a new study finds. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.
› Verified 4 days ago
Ms. Charlotte Tunnell, APN,RN Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 6231 Highland Place Way Ste 101, Knoxville, TN 37919 Phone: 865-264-2400 Fax: 865-588-6406 | |
Juliet Gladson, NP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 801 N Weisgarber Rd, Suite 200, Knoxville, TN 37909 Phone: 865-584-8588 Fax: 865-584-3364 | |
Lindsay G Frazier, APN Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 10215 Kingston Pike Ste 200, Knoxville, TN 37922 Phone: 865-584-8580 Fax: 865-251-9961 | |
Sally Marie Helton, MSN, APRN, PMH-CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2455 Sutherland Ave Bldg B, Knoxville, TN 37919 Phone: 865-558-9040 Fax: 865-000-0000 | |
Ms. Lucy Kniseley, MSN, RNCS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: Student Health Center University Of Tn, 1800 Volunteer Blvd, Knoxville, TN 37996 Phone: 865-974-2251 Fax: 865-974-7039 | |
Tasha Ligon, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4016 Peaks Landing Way, Apt 103, Knoxville, TN 37918 Phone: 865-237-8033 | |
Dale Gouldie, PNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 125 Huxley Rd, Knoxville, TN 37922 Phone: 865-691-3335 Fax: 865-691-3310 |